Mutation-independent Proteomic Signatures of Pathological Progression in Murine Models of Duchenne Muscular Dystrophy

The absence of the dystrophin protein in Duchenne muscular dystrophy (DMD) results in myofiber fragility and a plethora of downstream secondary pathologies. Although a variety of experimental therapies are in development, achieving effective treatments for DMD remains exceptionally challenging, not...

Descripción completa

Detalles Bibliográficos
Autores principales: van Westering, Tirsa L. E., Johansson, Henrik J., Hanson, Britt, Coenen-Stass, Anna M. L., Lomonosova, Yulia, Tanihata, Jun, Motohashi, Norio, Yokota, Toshifumi, Takeda, Shin'ichi, Lehtiö, Janne, Wood, Matthew J. A., EL Andaloussi, Samir, Aoki, Yoshitsugu, Roberts, Thomas C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710136/
https://www.ncbi.nlm.nih.gov/pubmed/32994316
http://dx.doi.org/10.1074/mcp.RA120.002345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710136/
https://www.ncbi.nlm.nih.gov/pubmed/32994316
http://dx.doi.org/10.1074/mcp.RA120.002345

Ejemplares similares